Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3499483013 | Ocrelizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3499484019 | Ocrelizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 64711000195111 | Ocrelizumab | de | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 828991000172114 | ocrélizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 50661000195118 | ocrelizumab | it | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ocrelizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Ocrelizumab | Is a | Immunomodulator | true | Inferred relationship | Some | ||
| Ocrelizumab | Has disposition (attribute) | Immunomodulator (disposition) | true | Inferred relationship | Some | ||
| Ocrelizumab | Is a | Immunologic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing ocrelizumab (medicinal product) | Has active ingredient | True | Ocrelizumab | Inferred relationship | Some | 1 |
| Ocrelizumab-containing product in parenteral dose form | Has active ingredient | True | Ocrelizumab | Inferred relationship | Some | 1 |
| Ocrelizumab only product | Has active ingredient | True | Ocrelizumab | Inferred relationship | Some | 1 |
| Ocrelizumab only product in parenteral dose form | Has active ingredient | True | Ocrelizumab | Inferred relationship | Some | 1 |
| Ocrelizumab therapy (procedure) | Direct substance | True | Ocrelizumab | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR